메뉴 건너뛰기




Volumn 11, Issue 4, 2011, Pages 227-229

Intravitreal anti-VEGF therapy with prompt or deferred laser compared with steroid with prompt laser and prompt laser alone for treatment of diabetic macular edema

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; TRIAMCINOLONE;

EID: 80051600604     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0201-3     Document Type: Article
Times cited : (6)

References (7)
  • 1
    • 80051585203 scopus 로고    scopus 로고
    • Centers for Disease Control 2011 National Diabetes Fact Sheet. Accessed on April 25, 2011
    • Centers for Disease Control 2011 National Diabetes Fact Sheet. Accessed on April 25, 2011 at http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf
  • 2
    • 0022347471 scopus 로고
    • Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1
    • Early Treatment Diabetic Retinopathy Study Research Group
    • Early Treatment Diabetic Retinopathy Study Research Group 1985 Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1796 1806
    • (1985) Arch Ophthalmol , vol.103 , pp. 1796-1806
  • 3
    • 29644444716 scopus 로고    scopus 로고
    • Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    • DOI 10.1016/j.ophtha.2005.10.012, PII S0161642005011863
    • Macugen Diabetic Retinopathy Study Group 2006 Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals Ophthalmology 113 23 28 10.1016/j.ophtha.2005.10.012 (Pubitemid 43021723)
    • (2006) Ophthalmology , vol.113 , Issue.1 , pp. 23-28
    • Bressler, N.M.1    Altaweel, M.2
  • 4
    • 70350567637 scopus 로고    scopus 로고
    • READ-2 Study Group. Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
    • 19700194 10.1016/j.ophtha.2009.04.023
    • QD Nguyen SM Shah JS Heier, et al. 2009 READ-2 Study Group. Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study Ophthalmology 116 2175 2181 19700194 10.1016/j.ophtha.2009.04.023
    • (2009) Ophthalmology , vol.116 , pp. 2175-2181
    • Nguyen, Q.D.1    Shah, S.M.2    Heier, J.S.3
  • 5
    • 7444245438 scopus 로고    scopus 로고
    • Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial
    • DOI 10.1016/j.ophtha.2004.05.025, PII S0161642004009248
    • FK Sutter JM Simpson MC Gillies 2004 Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial Ophthalmology. 111 11 2044 2049 15522370 10.1016/j.ophtha.2004.05.025 (Pubitemid 39446723)
    • (2004) Ophthalmology , vol.111 , Issue.11 , pp. 2044-2049
    • Sutter, F.K.P.1    Simpson, J.M.2    Gillies, M.C.3
  • 6
    • 0028120906 scopus 로고
    • Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
    • Antiplatelet Trialists' Collaboration
    • Antiplatelet Trialists' Collaboration 1994 Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 81 106
    • (1994) BMJ , vol.308 , pp. 81-106
  • 7
    • 79953299899 scopus 로고    scopus 로고
    • Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
    • Diabetic Retinopathy Clinical Research Network; Writing Committee Apr
    • Diabetic Retinopathy Clinical Research Network; Writing Committee, Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR, Scott IU, Stockdale CR, Sun JK. Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Ophthalmology. 2011 Apr;118(4):609-14.
    • (2011) Ophthalmology , vol.118 , Issue.4 , pp. 609-614
    • Elman, M.J.1    Bressler, N.M.2    Qin, H.3    Beck, R.W.4    Ferris Iii, F.L.5    Friedman, S.M.6    Glassman, A.R.7    Scott, I.U.8    Stockdale, C.R.9    Sun, J.K.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.